PD-L1 blockade by atezolizumab downregulates signaling pathways associated with tumor growth, metastasis, and hypoxia in human triple negative breast cancer
- Reem Saleh
- , Rowaida Z. Taha
- , Varun Sasidharan Nair
- , Nehad M. Alajez
- , Eyad Elkord*
*Corresponding author for this work
- Hamad bin Khalifa University
Research output: Contribution to journal › Article › peer-review
57
Link opens in a new tab
Citations
(Scopus)